Development of a prescribing indicator for objective quantification of antibiotic usage in secondary care

Journal of Antimicrobial Chemotherapy

Volumn 54, Issue 2, 2004, Pages 529-533

  Curtis, Chris ^a   Marriott, John ^b   Langley, Chris ^b  

^a QUEEN S HOSPITAL   (United Kingdom)

^b ASTON UNIVERSITY   (United Kingdom)

Author keywords

Antibiotic use; Defined daily doses; Electronic prescribing; Medicines management

Indexed keywords

ANTIBIOTIC AGENT;

ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG DOSE REGIMEN; DRUG UTILIZATION; HOSPITALIZATION; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; PRESCRIPTION; QUESTIONNAIRE; SCORING SYSTEM; SELF EVALUATION; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; WORLD HEALTH ORGANIZATION;

ANTI-BACTERIAL AGENTS; COHORT STUDIES; DATA COLLECTION; DRUG UTILIZATION; GREAT BRITAIN; HOSPITALS; HUMANS; MEDICATION SYSTEMS, HOSPITAL; PRESCRIPTIONS, DRUG; QUALITY ASSURANCE, HEALTH CARE; REPRODUCIBILITY OF RESULTS;

EID: 4444287312     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dkh362     Document Type: Article

References (25)

1. Consumers' Association. (1997). Medicines and the NHS: a Guide for Directors. Consumers' Association, London, UK.
2. National Prescribing Centre. (1999). Hospital Prescribing Information Project, Second Report. Analysis for Health Authority Prescribing Advisers and Senior Hospital Professionals/Managers. National Prescribing Centre, Liverpool, UK.
3. Hepler, D. & Strand, L. (1990). Opportunities and responsibilities in pharmaceutical care. American Journal of Hospital Pharmacy 47, 533-43.
4. Fitzpatrick, R., Mucklow, J. C. & Fillingham, D. (2001). A comprehensive system for managing medicines in secondary care. Pharmaceutical Journal 266, 585-8.
5. Castle, M., Wilfert, C. M., Cate, T. R. et al. (1977). Antibiotic use at Duke University Medical Centre. Journal of the American Medical Association 237, 2819-22.
6. Department of Health. (2003). Hospital Pharmacy Initiative For Promoting Prudent Use of Antibiotics in Hospitals. PL/PhO/2003/3. Department of Health, London, UK.
7. World Health Organization. (2001). WHO Global Strategy for Containment of Antimicrobial Resistance. World Health Organization, Geneva, Switzerland.
8. U.S. Congress. (1995). Impacts of Antibiotic-Resistant Bacteria. Office of Technology Assessment, Washington, DC, USA.
9. Commission of the European Communities. (2001). Council Recommendation on the Prudent Use of Antimicrobial Agents in Human Medicine, vol. 2, pp. 1-12. Commission of the European Communities, Brussels, Belgium.
10. Department of Health. (1999). Resistance to Antibiotics and Other Antimicrobial Agents. Department of Health, London, UK.
11. Department of Health. (2000). UK Antimicrobial Resistance Strategy and Action Plan, pp. 1-23. Department of Health, London, U K.
12. Department of Health. (1998). The Path of Least Resistance. Main Report of the Standing Medical Advisory Committee, Sub-group on Antimicrobial Resistance, p. 152. Department of Health, London, UK.
13. Select Committee on Science and Technology. (1998). Resistance to Antibiotics and Other Antimicrobial Agents.. House of Lords, Select Committee on Science and Technology, London, UK.
14. . Gould, I. M. (2001). Minimum antibiotic stewardship measures. Clinical Microbiology and Infection 7, Suppl. 6, 22-6.
15. Capella, D. (1993). Descriptive tools and analysis. In Drug Utilisation Studies. Methods and Uses (Dukes, M. N. G., Ed.), pp. 55-78. WHO Regional Publications, WHO Regional Office for Europe, Copenhagen, Denmark.
16. United Kingdom Drug Utilisation Research Group. (2000). Handbook of Drug Use Research Methodology, 1st edn (McGavock, H., Ed.) p. 255. Prescription Pricing Authority, Newcastle upon Tyne, UK.
17. WHO Collaborating Centre for Drug Statistics Methodology. (1999). ATC Index with DDDs. Oslo, Norway.
18. Wertheimer, A. I. (1986). The defined daily dose (DDD) system for drug utilization review. Hospital Pharmacy 21, 233-58.
19. Wessling, A. & Boethius, G. (1990). Measurement of drug use in a defined population. Evaluation of the defined daily dose (DDD) methodology. European Journal of Clinical Pharmacology 39, 207-10.
20. Curtis, C. E., Fitzpatrick, R. & Marriott, J. F. (2002). An evaluation of quinolone prescribing in a group of acute hospitals: development of an objective measure of usage. Pharmacy World and Science 24, 161-6.
21. Department of Health. (2004). HES Factsheet, Glossary of Terms. Department of Health, London, UK.
22. Department of Health (2000). Press release 12 December 2000. Health Minister Lord Hunt announces new framework to assess medicines management systems in hospitals. 2000/0733. Department of Health, London, UK.
23. Janknegt, R., Oude Lashof, A., Gould, I. M. et al. (2000). Antibiotic use in Dutch hospitals 1991-1996. Journal of Antimicrobial Chemotherapy 45, 251-6.
24. Kiivet, R. A., Dahl, M. L., Llerena, A. et al. (1998). Antibiotic use in 3 European university hospitals. Scandinavian Journal of Infectious Diseases 30, 277-80.
25. Vlahovic-Palcevski, V., Morovic, M., Palcevski, G. et al. (2001). Antimicrobial utilization and bacterial resistance at three different hospitals. European Journal of Epidemiology 17, 375-83.